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The Regulation and Development
of Bioremediation
Susan J. Timian & D. Michael Connolly*
Introduction
The U.S. faces an enormous task in cleaning up hazardous wastes.
Thousands of sites have been identified throughout the country, with
estimated cleanup costs over $1.7 trillion using existing technologies. 1
The most widely accepted technologies for waste treatment are
incineration and landfill disposal. Yet, these have serious drawbacks.
Incineration creates air pollution and ash to be discarded. Disposal in a
landfill does not treat waste, and space is decreasing as communities
are more reluctant to have hazardous wastes in their neighborhoods.
However, bioremediation has the potential of completely degrading
waste material with little or no toxic byproducts.2 It also has the
advantage of lower costs. Bioremediation has been shown to be effective
in both the Exxon Valdes oil spill and the Gulf War cleanups.3 In
fact, a variety of bioremediation techniques have been successfully
employed at over 400 cleanup sites throughout the U.S. at a cost
approximately 80-90% lower than other cleanup technologies. 4 For
these reasons, U.S. bioremediation revenues are climbing about
15-20% annually. They are expected to do so thru the year 2000,
5
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1 141 Cong. Rec. S11081 (daily ed. Aug. 1, 1995) (Statement of Sen. Feingold).
2 In fact, waste material may be used as a substrate for growing bacteria which
could produce useful materials.
3 N. M. Fayad, et al., Effectiveness of a Bioremediation Product in Degrading the
Oil Spilled in the 1991 Arabian Gulf War, 49 Bull. Environ. Contain. Toxicol. 787
(1992); P. H. Pritchard, et al., Oil Spill Bioremediation: Experiences, Lessons and
Results from the Exxon Valdes Oil Spill in Alaska, 3 Biodeg. 15 (1992).
4 Kevin Hamilton, U..S. Bioremediation Revenues Seen Climbing 16% a Year thru
2000, Hazardous Waste Business, Aug. 23, 1995, at 13.
5 Id.
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when the estimated annual spending on bioremediation products is
expected to top $500 million.6
The rapid growth of the bioremediation industry has been fueled
by regulations that limit the disposal of toxic compounds, driving up
the costs of disposal and making bioremediation attractive. Still, the
same regulations have hindered 'growth by favoring older technologies.
Furthermore, other regulations effectively prevent the use of genetically
altered microorganisms.
Many environmental regulations have driven the development of
bioremediation activities. For instance, amendments to the Clean Air
Act require that coal burning plants lower sulphur emissions.7 In
response, a Florida company, Microterra, has developed bacteria that
can reduce sulphur concentration in coal. 8
Even arms control agreements have spurred development of
bioremediation technologies. For example, the U.S. and the former
Soviet Union have agreed to dismantle most of their chemical weapons.
However, the disposal of the hazardous compounds resulting from this
dismantling, which are lethal in even minute quantities, has hampered
compliance with these agreements. For this reason, the U.S.
government has been developing microorganisms to degrade these
compounds into non-toxic products.
Although many different regulations on both the state and federal
level can affect the future of bioremediation, this report focuses upon
the federal statutes and regulations, both existing and under
development, which have the greatest impact on bioremediation. These
statutes are: the Resource Conservation and Recovery Act (RCRA)9
which regulates the treatment and disposal of hazardous materials; the
Comprehensive Environmental Response, Compensation and Recovery
Act (CERCLA), 10 more commonly known as "Superfund," that funds
6 Id.
7 42 U.S.C. % 7401-7626 (1994). The 1970 version was Pub. L. No. 91-604. The
1977 amendments were Pub. L. No. 95-95.
8 Matthew Gallagher, S0 2 Technologies, Sulphur Dioxide; Environmental
Strategies 95, Chemical Marketing Reporter, June 26, 1995, at SR-10 (Sulphur
emissions are the cause of acid rain.)
9 42 U.S.C. § 6901 et seq. (1994).
10 42 U.S.C. § 9601 et seq. (1994).
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cleanup of contaminated sites throughout the U.S.; and the Toxic
Substances Control Act (TSCA)1 1 that regulates the use of genetically
altered organisms.
How RCRA & CERCLA Encourage Bioremediation
RCRA and CERCLA are key factors in the development of
bioremediation. Since the passage of RCRA and CERCLA, industry
has had an enormous incentive to properly treat and dispose of its
hazardous wastes. RCRA provides strict standards for the treatment
and disposal of hazardous wastes. These standards are backed up by
harsh penalties which include not only fines, but criminal prosecution
for corporate executives. CERCLA imposes strict liability for the
cleanup costs on those manufacturers which release hazardous wastes
into the environment.
RCRA
RCRA was enacted in 1976 to identify and regulate wastes which
are hazardous to health and environment. It provides for a complex
system which regulates all aspects of hazardous waste storage, treatment
and disposal. Under RCRA, the U.S. Environmental Protection Agency
(EPA) has the responsibility of identifying hazardous wastes and the
authority to develop treatment standards for all hazardous wastes.
RCRA also provides for fines and criminal prosecution for violations of
RCRA requirements.
Management and disposal of all "hazardous waste" materials must
conform to RCRA standards and permitting procedures. The permit
spells out the methods for the treatment and handling of the hazardous
waste. During the permit process the permittee has the opportunity to
present plans to the EPA, which conform to statutory requirements.
Thousands of compounds are subject to RCRA permit
requirements. Waste is defined by the statute "as any solid or liquid
material which is intended to be discarded." The EPA has two broad
categories for hazardous wastes, characteristic waste and listed waste.
Characteristic waste displays one of four listed characteristics:
ignitability, reactivity, corrosivity or toxicity. 12 The EPA defines
11 15 U.S.C. § 2601 et seq. (1994)
12 40 C.F.R. § 261.20. (1995)
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specific tests for determining whether waste has one of these
characteristics. 13 Listed wastes, on the other hand, are specifically
identified by the EPA as hazardous. 14 A listed waste may, but does
not necessarily, demonstrate one or more of the four characteristics
discussed above. Presently, several hundred compounds are listed as
hazardous waste.
A key exemption to the Act which benefits bioremediation, is the
exclusion of an enclosed treatment facility from RCRA permitting
requirements. A totally enclosed facility is a facility directly connected
to an industrial process site in a manner which prevents the release of
any hazardous waste during treatment. Therefore, bioreactors installed
in a plant may qualify as a totally enclosed treatment facility. For the
purposes of RCRA, the treatment is part of the process and no
hazardous waste material is produced. However, care must be taken to
assure that the material released from the plant is not hazardous.
CERCLA
CERCLA provides the EPA with the authority to cleanup sites
contaminated with hazardous wastes. The legislation also allows the
government to impose the cost of cleanup onto responsible parties. 15
CERCLA is a strict liability statute, requiring no negligence or intent.
Furthermore, there is no time limit on potential liability. Those that
create, treat or store the hazardous waste can always be held liable for
its cleanup. CERCLA therefore provides a tremendous incentive to find
and utilize inexpensive means of converting hazardous waste into
nonhazardous material.
The Act requires that a potential cleanup site go through an
assessment. The first stage identifies any potentially responsible parties.
A remedial investigation is then conducted to determine the nature and
extent of the contamination. Next, a feasibility study is conducted to
evaluate alternative methods of treating the contamination. After the
evaluations are complete, the EPA issues a "record of decision," that
identifies the treatment procedure to be carried out at the site.
13 See 40 C.F.R. § 261.21 (ignitability); 40 C.F.R. § 261.22 (corrosivity); 40
C.F.R. § 261.23 (reactivity); and 40 C.F.R. § 261.24 (toxicity).
14 40 C.F.R § 261.30.
15 Only if the responsible parties cannot be found or are unable to fund the cleanup,
will the government pay for the cleanup out of the "superfund."
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In 1986, CERCLA was amended by the Superfund Amendments
and Reorganization Act (SARA). At that time Congress sought to
encourage the development of new technologies which were not
available at the time of the original act. Section 121(b) of SARA
requires the EPA to "conduct an assessment of permanent solutions and
alternative technologies or resource recovery technologies". Special
emphasis was placed on those technologies which could permanently
decrease the level of pollutants. Congress further provided for a
"program of research, evaluation, testing, development, and
demonstration of alternative or innovative treatment technologies" in
section 311 (b) of SARA.
How RCRA and CERCLA Inhibit Bioremediation Development
Even though RCRA and CERCLA require treatment of hazardous
wastes and the cleanup of contaminated sites, these statutes also have
standards which discourage the use of bioremediation. For example,
RCRA and CERCLA both require the use of the "best demonstrated
available technology" (BDAT), for treatment and cleanup. This creates
artificially high standards which cannot be reached with biological
technologies. Further, the "derived from" rule requires that any
hazardous waste which is treated must still be handled as if it is
hazardous waste, even if bioremediation converts the hazardous
material to a nonhazardous material.
Best DemonstratedAvailable Technology Requirements
The EPA requires that treatment standards be set based upon the
BDAT. Conventional technologies, such as incineration, may result in
lower contamination levels than those obtained using bioremediation,
resulting in such conventional technologies being considered the "best"
demonstrated available technology. The resulting standards therefore,
are not based on the levels necessary to protect health and environment,
but are arbitrarily set by the available technology. Furthermore, the
ability to achieve lower levels of contamination is not the sole factor in
determining the desirability of a cleanup procedure. For example, to
cleanup a spill of hazardous material by incineration, the contaminated
soil and other material must be removed from the area, which disrupts
the environment. The material must then be burned, releasing
7 Rislk Health, Safety & Environment 279 [Summer 1996]
pollutants into the air, and requiring the disposal of the resulting ash in
a landfill. Alternatively, bioremediation can be accomplished with
minimal disruption to the environment and without creating other
pollution problems.
The Derived From Rule
Several EPA policies expand. the definitions of hazardous waste. To
prevent the disposal of hazardous wastes by diluting the wastes with
other waste, the EPA adopted a "mixture rule." It provides that any
mixture of a solid waste with a hazardous waste is still to be considered
a hazardous waste. EPA policies also provide that material such as soil
or water which contains hazardous waste is also a hazardous waste. 16
The EPA further has a "derived from" rule which provides that any
residue derived from the treatment of listed hazardous waste, such as
the waste from a bioreactor, must be treated as hazardous waste. 17
Here the distinction between characteristic waste and listed waste is
important. Characteristic waste may be rendered nonhazardous by
treatment to the point where the resulting waste no longer
demonstrates the hazardous characteristic. 18 However, a listed
hazardous waste "will remain a hazardous waste" even after
treatment. 19 Therefore, the generator of a listed hazardous waste who
effectively treats the waste through bioremediation must still treat the
material generated as hazardous waste.2 0
Bioremediation has potential to convert hazardous material into
innocuous compounds. The regulations could encourage the use of
bioremediation if standards were set for treatment which would allow
the remaining innocuous waste material to be classified as
nonhazardous. Generators of waste would have an incentive to treat the
waste rather than storing or disposing of the material in approved
hazardous waste dumps. They would realize cost savings by avoiding
16 40 C.F.R. § 261.3(b)(2).
17 40 C.F.R. § 261.3(c)(2)(i).
18 40 C.F.R1 § 261.3(a)(2)(iii),(d)(1).
19 40 C.F.R. § 261.3(c)(1).
20 But see 40 C.F.R. § 261.3(c)(2)(i). An exception does exist for material which is
reclaimed from the treatment process and retains beneficial uses. For example, if
bacteria used to degrade hazardous waste converted the material into a useful
product, the product isolated from the bacteria would not be a waste and therefore
would not be a hazardous waste.
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the need to dispose of the hazardous waste, and would avoid potential
future liability for any cleanups of the material required under
CERCLA.
Regulating Use of Genetically Engineered Microorganisms
Bioremediation is limited to treating wastes which can be effectively
recognized and degraded by microorganisms. Many types of toxic
waste are difficult to degrade because of a lack of microorganisms
which will recognize and transform the waste. Microorganisms which
have evolved over millions of years have not been exposed to the
thousands of man-made compounds until relatively recently.
Therefore, the bacteria have not had the opportunity to evolve systems
to efficiently degrade these waste compounds. Genetically altered
organisms could expand the range of compounds and the number of
sites at which bioremediation could be used.
Genetic engineering of microorganisms provides a method of
creating bacteria which can recognize and degrade these nonnatural
compounds. A quick review of the literature finds hundreds of articles
concerned with the engineering of bacteria better suited for degrading
toxic waste.
However, to date no genetically altered microorganism has been
used commercially to cleanup or degrade toxic wastes, primarily due to
a lack of government approval. The EPA has the authority to regulate
the release of microorganisms under section 5 of the TSCA.2 1
Although the EPA was granted this authority almost twenty years ago,
it has approved only a small number of demonstration projects
involving closed reactor systems. 2 2
TSCA
TSCA was enacted in 1976 to enable the EPA to screen new
substances prior to their introduction into commerce and to regulate
those compounds which present a risk to health or environment.23 The
EPA also has the authority under TSCA to regulate the use of existing
and new substances which are unsafe to health or environment. 2 4
21 Occasionally, the U.S. Department of Agriculture will be involved if the
genetically altered organism falls within the scope of the Federal Plant Pest Act.
22 Hamilton, supra note 4.-
23 15 U.S.C. §§ 2604 and 2605.
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However, TSCA does not apply to pesticides, food and food additives,
or drugs and cosmetics, which are subject to regulation by other
statutes and agencies. 25
In 1984, the Office of Science and Technology prepared a proposal
for a Coordinated Framework for Regulation of Biotechnology.2 6 As
part of this reworking of biotech-nology regulations, the EPA published
a proposed policy statement in which it stated that the definition of
"new chemical substances" included living organisms and
microorganisms. 2 7 This Policy Statement was officially adopted in
1986. The EPA now specifically defines intergeneric microorganisms
(microorganisms which have DNA from an organism of a different
genera) as "new chemical substances" subject to review under TSCA.
Section 5 of TSCA, which is particularly relevant to bioremediation
technologies, requires that the manufacturer of a new chemical
substance submit a premanufacture notice (PMN) to the EPA.2 8 A
new chemical substance is any material which is not implicitly or
explicitly listed on the TSCA Inventory of Chemical Substances.2 9 A
chemical substance is implicitly listed in the inventory if it is considered
to be already in commerce in the U.S. A chemical substance is explicitly
listed when a manufacturer files a Notice of Commencement (NOC),
indicating the intent to use an approved substance in commerce. Once a
chemical substance is listed in the TSCA inventory, other persons may
use the substance without notifying the EPA.
The PMN must be submitted at least 90 days prior to introducing
the new substance into commerce. 30 The manufacturer must identify
the chemical, its proposed uses, and the projected amount of use.3 1 In
addition, the applicant must submit any known data regarding the
environmental and health effects of the substance. 32 The EPA then
24 15 U.S.C. § 2604(e).
25 15 U.S.C. § 2602(2).
26 49 Fed. Reg. 50856 (1984).
27 Proposed Policy Regarding Certain Microbial Products, 49 Fed. Reg. 50886
(1984).
28 15 U.S.C. § 2604.
29 15 U.S.C. § 2607(b).
30 The EPA publishes a document with points to consider when submitting a PMN
for a genetically engineered microorganism.
31 15 U.S.C. § 2604(a).
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conducts a review to determine whether the material possesses an
unreasonable risk to health or environment. If an unreasonable risk is
found, the EPA may prohibit or limit its manufacture.
Naturally occurring microorganisms are considered to be implicitly
listed in the TSCA inventory. Therefore, the use of natural
microorganisms is generally not subject to review under TSCA. Also
implicitly included in the inventory, are intrageneric organisms
(organisms whose introduced genetic material is derived from
microorganisms of the same genera). However, the EPA may designate
new uses of chemical substances as "significant new uses," and require
the submission of a PMN and review by the agency. Nevertheless,
bioremediation with naturally occurring organisms is not significantly
impacted by TSCA.3 3
No genetically modified microorganism has yet been approved for
commercial use. However, the EPA should grant approval for the use of
a modified Rhizobium meliloti in the next few months. 34
Proposed Rules for Use of Genetically Engineered Microorganisms
In September of 1994, the EPA released proposed rules for the
regulation of microbial products of biotechnology under TSCA. Most
importantly, for the first time the rules are specifically directed to the
regulation of genetically engineered microorganisms.
In 1986, when the EPA expanded the scope of TSCA, it realized
that new regulations were needed for genetically engineered
microorganisms. However, through a lack of initiative on the part of the
EPA and activity by large biotechnology firms, these new rules have
been delayed. These proposed rules are expected to be finalized in June
of 1996 and will become effective 60 days after they are published in
final form.3 5
Even with the expected delays which will occur during an election
year, these proposed rules will affect those microorganisms which are
32 15 U.S.C. § 2604(b).
33 J. S. Baskt, Impact of Present and Future Regulations on Bioremediation, 8 J.
Ind. Microbiol. 13 (1991).
34 See, Science Advisory Panel Split Over Need for Further Testing of Microbe;
Member Resigns, BNA National Environment Daily, Mar. 9, 1995, available in Lexis
BNA Library, BNAIED file.
35 60 Fed. Reg. 23957 (1995).
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presently being developed. For this reason, manufacturers should look
to the new rules when designing their research projects, in order to
facilitate the regulatory process. It should be noted that even prior to
the proposed rules becoming effective, these approaches will be useful
when seeking approval for release of a genetically engineered
microorganism (GEM).
Under the new rules, a manufacturer will submit a Microbial
Commercial Activity Notice (MCAN), rather than a PMN. The
MCAN must identify the recipient microorganism and describe its
phenotypic and ecological characteristics, as well as a detailed
description of its genetic modification. 3 6 The proposed rule also
requires the manufacturer to provide (i) health effects data, (ii)
ecological effects data, (iii) physical and chemical properties data, (iv)
environmental fate, and (v) monitoring or test data related to human
exposure or environmental release. 37 If the information is available in
the open scientific literature, the manufacturer need only provide a
citation. However, if the information is not available in the literature,
the manufacturer must provide a full report of all the necessary studies.
These studies are time consuming and expensive. However, the
proposed rules do provide some limited exemptions which include ten
well characterized recipient microorganisms. 38 In order to qualify for
an exemption, the introduced genetic material must be limited in size
to include only the structural genes of interest, regulatory sequences,
sequences needed to insert the gene into a plasmid, and the sequences
needed to transfer and maintain the vector. 3 9 Furthermore, the
genetic material must be free of nucleotide sequences which encode
identified toxins.4 0
A manufacturer may avoid significant cost and delay by designing a
GEM to fit within the exceptions provided by the EPA. First, if it is
possible, a manufacturer should choose to use one of the recipient
36 59 Fed. Reg. 45572 (1994) (Proposed 40 C.F.R. §725.155(d)).
37 59 Fed. Reg. 45573 (1994) (Proposed 40 C.F.R. §725.160).
38 These microorganisms are: Acetobacter aceti, Aspergillus niger, Aspergillus
oryzae, Bacillus lichenformis, Bacillus subtilis, Clostridium acetobutylicum,
Escherichia coli K-12, Penicillium roqueforti, Saccharomyces cerevisiae, and
Saccharomyces uvarum. 59 Fed. Reg. 4579 (1994); EPA officials have indicated that
several Rhizobium species should be added to this list in the near future.
39 Id. (Proposed 40 C.F.R. § 725.421).
40 The toxins are listed in the proposed 40 C.F.Rt § 725.421(d) (1994).
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microorganisms which is eligible for exemption. Second, they should
carefully construct all introduced DNA in a manner as not to include
uncharacterized DNA. Providing the EPA with a well defined DNA
construct can greatly facilitate the review process. According to the
EPA, constructs with uncharacterized DNA and poorly constructed
genetic maps are responsible for considerable delay in approval.
When the listed microorganisms are not suitable for a
manufacturer's needs, a risk assessment must be carried out for the
recipient organism. The EPA will add additional organisms to the list
as they collect enough data to complete a risk assessment. However, the
manufacturer does not need to wait for an organism to be listed as an
eligible exemption, as he may submit the needed information. 4 1
Because of the time required to collect the information, a manufacturer
should begin the process as early as possible. Thus, as soon as the new
organism is developed, it may be possible to exempt it from the
reporting requirements.
Although there is improvement, the new rules are still burdensome
and as yet not risk based. The new regulations still regard molecular
genetic modification as per se high risk, rather than regulating high risk
organisms or uses of organisms. In 1989, the U.S. National Research
Council concluded that "no conceptual distinction exists between
genetic modification of plants and microorganisms by classical
methods or by molecular methods that modify DNA and transfer
genes." 4 2 EPA policies regarding the release of genetically modified
microorganisms still avoid any type of risk based analysis.
Practical experience with genetically modified microorganisms
indicates that they are not per se hazardous to the environment. Over
the years, researchers have released thousands of different such
organisms into the environment with no reported problems.
41 Risk assessment documents for the approved organisms are available from the
EPA as examples of the information required to complete a risk assessment for the
recipient organisms.
42 National Academy of Sciences, Field Testing Genetically Modified Organisms:
Framework for Decisions (1989).
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Federal Plant PestAct
The Federal Plant Pest Act (FPPA) regulates the release of
organisms "which can directly or indirectly injure or cause disease or
damage in any plants". Therefore, the FPPA would only be applicable
in those cases where the microorganism is a plant pest or if it was
genetically engineered with DNA from a plant pest and caused damage
to plants. 4 3 Like TSCA, the FPPA regulates the use of genetically
engineered microorganisms regardless of risk.
Conclusion
The passage of extensive environmental regulations over the past
twenty years has resulted in a demand for improved waste disposal and
cleanup technologies. Practical experience has shown that
bioremediation can be effective and cost efficient in certain cleanup
situations. However, wider usage of the technology has been inhibited
by federal regulations which were developed before the advent of
effective bioremediation and which favor more established
technologies. These regulations need to be updated to include risk
based criteria in cleanup and treatment requirements.
Genetic engineering provides the tools needed to expand the range
of target compounds and increase the effectiveness of bioremediation.
However, EPA regulations have prevented the use of GEMs in
bioremediation. Recently, the EPA has acted to change these
regulations in order to encourage the development of GEM
technologies, but as yet the new regulations still regulate all products of
genetic engineering irrespective of risk.
43 7 C.F.R. Part 340. (1996)
